EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Incretin-Based Therapies in Sports: Pharmacological Mechanisms, Performance-Enhancing Potential, and Anti-Doping Implications—A Narrative Review

Sandro La Vignera iD, Rosita A Condorelli iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27146116 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Sandro La Vignera und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy. Hauptthemen laut MEDLINE: Incretins, Doping in Sports, Athletic Performance, Performance-Enhancing Substances. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Incretin-based therapies, including glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dipeptidyl peptidase-4 (DPP-4) inhibitors, have revolutionized the management of type 2 diabetes and obesity. Recent evidence suggests these agents may influence athletic performance through effects on body composition, energy metabolism, and cardiovascular function. This narrative review critically evaluates whether incretin therapies could constitute doping under World Anti-Doping Agency (WADA) criteria. We narratively reviewed the literature on incretin pharmacology, metabolic effects relevant to athletic performance, and anti-doping regulations, searching PubMed, Scopus, and Web of Science using terms including “GLP-1 receptor agonists”, “DPP-4 inhibitors”, “doping”, “athletic performance”, “WADA”, and “sports pharmacology”, without date restrictions. GLP-1 RAs (semaglutide, liraglutide, tirzepatide, exenatide) induce substantial weight loss (predominantly fat mass) but also reduce lean mass by 20–30% of total weight loss. Preclinical studies demonstrate enhanced exercise endurance, mitochondrial biogenesis, and glucose uptake via GLP-1R/AMPK signaling. However, clinical trials show no consistent improvement in physical performance in humans. Currently, incretin therapies are not listed on the WADA Prohibited List. While incretin therapies offer theoretical performance-enhancing potential through weight management and metabolic optimization, current evidence does not support classification as doping agents. Continued surveillance is warranted as misuse patterns emerge.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IncretinsDoping in SportsAthletic PerformancePerformance-Enhancing SubstancesHumansAnimalsGlucagon-Like Peptide-1 Receptor AgonistsDipeptidyl-Peptidase IV InhibitorsEnergy MetabolismDiabetes Mellitus, Type 2Tirzepatide

Stichwörter der Autor:innen

GLP-1 receptor agonistsWADAanti-dopingathletic performancebody compositiondopingincretin therapyliraglutidesemaglutidesports pharmacology

Substanzen

IncretinsGlucagon-Like Peptide-1 Receptor AgonistsDipeptidyl-Peptidase IV InhibitorsTirzepatidePerformance-Enhancing Substances

Autor:innen und Institutionen

  • Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.

ORCID-Profile: Sandro La Vignera, Rosita A Condorelli

Zitieren

APA

La Vignera, S., & Condorelli, R. A. (2026). Incretin-Based Therapies in Sports: Pharmacological Mechanisms, Performance-Enhancing Potential, and Anti-Doping Implications—A Narrative Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27146116

Vancouver

La Vignera S, Condorelli RA. Incretin-Based Therapies in Sports: Pharmacological Mechanisms, Performance-Enhancing Potential, and Anti-Doping Implications—A Narrative Review. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27146116

BibTeX
@article{LaVignera2026,
  author = {La Vignera, Sandro and Condorelli, Rosita A},
  title = {Incretin-Based Therapies in Sports: Pharmacological Mechanisms, Performance-Enhancing Potential, and Anti-Doping Implications—A Narrative Review},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27146116}
}
Kostenlos starten →